Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Expression of TNFRSF25 on conventional T cells and Tregs.

Taraban VY, Ferdinand JR, Al-Shamkhani A.

J Clin Invest. 2011 Feb;121(2):463-4; author reply 465. doi: 10.1172/JCI45832. Epub 2011 Feb 1. No abstract available.

2.

Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Slebioda TJ, Rowley TF, Ferdinand JR, Willoughby JE, Buchan SL, Taraban VY, Al-Shamkhani A.

Eur J Immunol. 2011 Sep;41(9):2606-11. doi: 10.1002/eji.201141477. Epub 2011 Aug 4.

3.

Death receptor 3 signaling enhances proliferation of human regulatory T cells.

Bittner S, Knoll G, Ehrenschwender M.

FEBS Lett. 2017 Apr;591(8):1187-1195. doi: 10.1002/1873-3468.12632. Epub 2017 Apr 10.

4.

The role of TNFRSF25:TNFSF15 in disease… and health?

Schreiber TH, Wolf D, Podack ER.

Adv Exp Med Biol. 2011;691:289-98. doi: 10.1007/978-1-4419-6612-4_30. Review. No abstract available.

PMID:
21153333
5.

Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.

Sidhu-Varma M, Shih DQ, Targan SR.

Inflamm Bowel Dis. 2016 Mar;22(3):548-59. doi: 10.1097/MIB.0000000000000653.

6.

TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.

Meylan F, Richard AC, Siegel RM.

Immunol Rev. 2011 Nov;244(1):188-96. doi: 10.1111/j.1600-065X.2011.01068.x. Review.

7.

Cloning, expression, and functional characterization of TL1A-Ig.

Khan SQ, Tsai MS, Schreiber TH, Wolf D, Deyev VV, Podack ER.

J Immunol. 2013 Feb 15;190(4):1540-50. doi: 10.4049/jimmunol.1201908. Epub 2013 Jan 14.

8.

Immunobiology of TNFSF15 and TNFRSF25.

Schreiber TH, Podack ER.

Immunol Res. 2013 Dec;57(1-3):3-11. doi: 10.1007/s12026-013-8465-0. Review.

PMID:
24242819
9.

Introductory words about TL1A/DR3.

Targan SR.

Adv Exp Med Biol. 2011;691:271-4. doi: 10.1007/978-1-4419-6612-4_27. No abstract available.

PMID:
21153330
10.

Soluble TL1A is sufficient for activation of death receptor 3.

Bittner S, Knoll G, Füllsack S, Kurz M, Wajant H, Ehrenschwender M.

FEBS J. 2016 Jan;283(2):323-36. doi: 10.1111/febs.13576. Epub 2015 Nov 24.

11.

Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.

Wolf D, Schreiber TH, Tryphonopoulos P, Li S, Tzakis AG, Ruiz P, Podack ER.

Transplantation. 2012 Sep 27;94(6):569-74.

PMID:
22902792
12.

Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.

Perks WV, Singh RK, Jones GW, Twohig JP, Williams AS, Humphreys IR, Taylor PR, Jones SA, Wang ECY.

Am J Pathol. 2016 Nov;186(11):2813-2823. doi: 10.1016/j.ajpath.2016.07.021. Epub 2016 Sep 21.

13.

Insights into TL1A and IBD pathogenesis.

Shih DQ, Michelsen KS, Barrett RJ, Biener-Ramanujan E, Gonsky R, Zhang X, Targan SR.

Adv Exp Med Biol. 2011;691:279-88. doi: 10.1007/978-1-4419-6612-4_29. Review. No abstract available.

PMID:
21153332
14.

Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.

Liu C, Li XX, Gao W, Liu W, Liu DS.

PLoS One. 2014 Mar 20;9(3):e92743. doi: 10.1371/journal.pone.0092743. eCollection 2014.

15.

Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.

Liu A, Hu P, Khawli LA, Epstein AL.

Clin Cancer Res. 2005 Dec 1;11(23):8492-502.

16.

TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers.

Yu X, Pappu R, Ramirez-Carrozzi V, Ota N, Caplazi P, Zhang J, Yan D, Xu M, Lee WP, Grogan JL.

Mucosal Immunol. 2014 May;7(3):730-40. doi: 10.1038/mi.2013.92. Epub 2013 Nov 13.

17.

Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.

Bamias G, Evangelou K, Vergou T, Tsimaratou K, Kaltsa G, Antoniou C, Kotsinas A, Kim S, Gorgoulis V, Stratigos AJ, Sfikakis PP.

Exp Dermatol. 2011 Sep;20(9):725-31. doi: 10.1111/j.1600-0625.2011.01304.x. Epub 2011 Jun 14.

PMID:
21672030
18.

Control of regulatory T cell development by the transcription factor Foxp3.

Hori S, Nomura T, Sakaguchi S.

Science. 2003 Feb 14;299(5609):1057-61. Epub 2003 Jan 9.

19.

Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, Kronenberg M, Cheroutre H, Ware CF.

J Immunol. 2001 Dec 1;167(11):6330-7.

20.

Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.

Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY.

Mol Immunol. 2011 Oct;49(1-2):219-26. doi: 10.1016/j.molimm.2011.08.016. Epub 2011 Oct 2.

PMID:
21963221

Supplemental Content

Support Center